Base de données de recherche subventionnée canadienne sur la COVID-19

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 111 through 120 of 185 results (Download Results)

Show results per page

Reducing the Health Care Resource Burden from COVID‑19 (SARS-CoV-2): Rapid Diagnostics to Risk-Stratify for Severity of Illness

Keshavjee, Shaf | University Health Network | Operating Grant | $970,702

CIHR Ontario 2020

Assessment of Cancer Patient and Caregiver Perspective on the Novel Coronavirus (COVID-19) and the Impact on Delivery of Cancer Care at an Institution with a Confirmed Case of COVID-19

Singh, Simron | Sunnybrook Odette Cancer Centre | Operating Grant | $44,700

CIHR Ontario 2020

Therapeutic Development for COVID‑19 Coronavirus Induced Sepsis and ARDS Targeting Vascular Leakage

Lee, Warren L | Unity Health Toronto | Operating Grant | $953,819

CIHR Ontario 2020

Indigenous Health Counts in Urban Homelands: Estimating COVID‑19 Incidence and Mortality among Indigenous Populations Living in Ontario Cities

Rotondi, Michael A | York University | Operating Grant | $395,460

CIHR Ontario 2020

What is the public health risk communication response to COVID‑19 in the context of social media?

Kothari, Anita R | Western University | Operating Grant | $129,595

CIHR Ontario 2020

Rapid development of antiviral compounds to fight the COVID‑19 outbreak

Sidhu, Sachdev S | University of Toronto | Operating Grant | $886,090

CIHR Ontario 2020

Ethical Pathways for Therapeutics and Vaccine R&D in the Context of Public Health Emergencies of International Concern: An Analysis of the 2013-16 Ebola Outbreak to Rapidly Inform COVID‑19 R&D

Smith, Maxwell | Western University | Operating Grant | $283,656

CIHR Ontario 2020

Development of a Predictive Serologic Test for Cytopathogenic Autoantibodies in COVID‑19 Patients

Rottapel, Robert K | University Health Network | Operating Grant | $215,475

CIHR Ontario 2020

Sex as a Biological Variable Supplement – Molecular and cellular therapies against COVID‑19 using angiotensin-converting enzyme 2 (ACE2)

Zhang, Haibo | Keenan Research Centre | Operating Grant | $50,000

CIHR Ontario 2020

Sedating With Volatile Anesthetic Agents in Critically Ill COVID‑19 Patients in ICU: Effects On Ventilatory Parameters And Survival (The SAVE-ICU trial)

Jerath, Angela | Sunnybrook Research Institute | Operating Grant | $2,020,648

CIHR Ontario 2020

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Reducing the Health Care Resource Burden from COVID‑19 (SARS-CoV-2): Rapid Diagnostics to Risk-Stratify for Severity of Illness

Assessment of Cancer Patient and Caregiver Perspective on the Novel Coronavirus (COVID-19) and the Impact on Delivery of Cancer Care at an Institution with a Confirmed Case of COVID-19

Therapeutic Development for COVID‑19 Coronavirus Induced Sepsis and ARDS Targeting Vascular Leakage

Indigenous Health Counts in Urban Homelands: Estimating COVID‑19 Incidence and Mortality among Indigenous Populations Living in Ontario Cities

What is the public health risk communication response to COVID‑19 in the context of social media?

Rapid development of antiviral compounds to fight the COVID‑19 outbreak

Ethical Pathways for Therapeutics and Vaccine R&D in the Context of Public Health Emergencies of International Concern: An Analysis of the 2013-16 Ebola Outbreak to Rapidly Inform COVID‑19 R&D

Development of a Predictive Serologic Test for Cytopathogenic Autoantibodies in COVID‑19 Patients

Sex as a Biological Variable Supplement – Molecular and cellular therapies against COVID‑19 using angiotensin-converting enzyme 2 (ACE2)

Sedating With Volatile Anesthetic Agents in Critically Ill COVID‑19 Patients in ICU: Effects On Ventilatory Parameters And Survival (The SAVE-ICU trial)